Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rhea J Longley

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Clinical and Vaccine Immunology : CVI|December 15, 2015
Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western ThailandRhea J Longley, Arturo Reyes-Sandoval, Eduardo Montoya-Díaz, et al.
Pharmacogenomics and Personalized Medicine|February 6, 2020
Pharmacogene Variation in Thai <i>Plasmodium vivax</i> Relapse Patients Treated with a Combination of Primaquine and ChloroquineMonpat Chamnanphon, Andrea Gaedigk, Apichaya Puangpetch, et al.
The American Journal of Tropical Medicine and Hygiene|September 8, 2016
High Efficacy of Primaquine Treatment for Plasmodium vivax in Western ThailandRhea J Longley, Piyarat Sripoorote, Pornpimol Chobson, et al.
Scientific Reports|September 18, 2021
Sensitive detection of Plasmodium vivax malaria by the rotating-crystal magneto-optical method in ThailandÁgnes Orbán, Rhea J Longley, Piyarat Sripoorote, et al.
BMC Infectious Diseases|April 16, 2025
Applying novel Plasmodium Vivax serological exposure markers to quantify residual malaria transmission in the Philippines through repeated health facility surveys: the SMaRT study protocolJhobert Bernal, Maria Lourdes Macalinao, Katherine Cosca, et al.
Scientific Reports|July 4, 2015
Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidatesRhea J Longley, Ahmed M Salman, Matthew G Cottingham, et al.
The Lancet Regional Health. Western Pacific|March 31, 2025
Evaluating the technical feasibility of serological testing and treatment for <i>Plasmodium vivax</i> in mobile at-risk of malaria Cambodian populationsCostanza Tacoli, Sopheany Thin, Malen Ea, et al.
Malaria Journal|April 30, 2026
Sociodemographic and behavioral determinants of Plasmodium vivax-specific antibody responses among short-term Myanmar migrants in ThailandPiyarat Sripoorote, Nichakan Inthitanon, Yupaporn Wattanagoon, et al.
Frontiers in Cellular and Infection Microbiology|February 10, 2023
Identification of novel <i>Plasmodium vivax</i> proteins associated with protection against clinical malariaRamin Mazhari, Eizo Takashima, Rhea J Longley, et al.
Plos One|June 20, 2014
Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chainAlexandra J Spencer, Matthew G Cottingham, Jennifer A Jenks, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Clinical and Vaccine Immunology : CVI|December 15, 2015
Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western ThailandRhea J Longley, Arturo Reyes-Sandoval, Eduardo Montoya-Díaz, et al.
Pharmacogenomics and Personalized Medicine|February 6, 2020
Pharmacogene Variation in Thai <i>Plasmodium vivax</i> Relapse Patients Treated with a Combination of Primaquine and ChloroquineMonpat Chamnanphon, Andrea Gaedigk, Apichaya Puangpetch, et al.
The American Journal of Tropical Medicine and Hygiene|September 8, 2016
High Efficacy of Primaquine Treatment for Plasmodium vivax in Western ThailandRhea J Longley, Piyarat Sripoorote, Pornpimol Chobson, et al.
Scientific Reports|September 18, 2021
Sensitive detection of Plasmodium vivax malaria by the rotating-crystal magneto-optical method in ThailandÁgnes Orbán, Rhea J Longley, Piyarat Sripoorote, et al.
BMC Infectious Diseases|April 16, 2025
Applying novel Plasmodium Vivax serological exposure markers to quantify residual malaria transmission in the Philippines through repeated health facility surveys: the SMaRT study protocolJhobert Bernal, Maria Lourdes Macalinao, Katherine Cosca, et al.
Scientific Reports|July 4, 2015
Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidatesRhea J Longley, Ahmed M Salman, Matthew G Cottingham, et al.
The Lancet Regional Health. Western Pacific|March 31, 2025
Evaluating the technical feasibility of serological testing and treatment for <i>Plasmodium vivax</i> in mobile at-risk of malaria Cambodian populationsCostanza Tacoli, Sopheany Thin, Malen Ea, et al.
Malaria Journal|April 30, 2026
Sociodemographic and behavioral determinants of Plasmodium vivax-specific antibody responses among short-term Myanmar migrants in ThailandPiyarat Sripoorote, Nichakan Inthitanon, Yupaporn Wattanagoon, et al.
Frontiers in Cellular and Infection Microbiology|February 10, 2023
Identification of novel <i>Plasmodium vivax</i> proteins associated with protection against clinical malariaRamin Mazhari, Eizo Takashima, Rhea J Longley, et al.
Plos One|June 20, 2014
Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chainAlexandra J Spencer, Matthew G Cottingham, Jennifer A Jenks, et al.
Pageof 6